Stock

Mineralys Therapeutics, Inc. MLYS

Market data for MLYS is refreshing — check back shortly.

All stocks Create account to unlock

Overview

MLYS market data

Price History

No market bars yet for MLYS. This page will populate once the next provider sweep lands.

Valuation & Profitability

no valuation data

No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for MLYS. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

6 captured

Mineralys to Present New Trial Data at ENDO 2026, Proteomic Analysis Selected for Late-Breaking ENDO Poster · Jun 8, 2026, 11:20 AM

Mineralys Therapeutics to Present Late-Breaking Data on Lorundrostat at The Endocrine Society Annual Meeting (ENDO 2026) · Jun 8, 2026, 11:15 AM

8-K filing — Mineralys Therapeutics, Inc. (MLYS) · Jun 3, 2026, 8:07 PM

Mineralys Therapeutics Announces Repurchase of Royalty Obligations in Tanabe License Agreement and Concurrent Financing · Jun 3, 2026, 11:15 AM

Mineralys Therapeutics To Feature Data From Phase 3 Launch-HTN Trial At ESH 2026 · May 18, 2026, 8:15 PM

AstraZeneca Scores Key FDA Wins Across Cardiovascular And Oncology Portfolios · May 18, 2026, 5:05 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock